Remedium Life

Market Cap: Micro Cap
Industry: Trading & Distributors
ISIN: INE549S01036
NSEID:
BSEID: 539561

INR

0.95

-0.04 (-4.04%)

BSENSE

Dec 05

BSE+NSE Vol: 1.37 cr

{
  "main_header": {
    "sid": 857841,
    "name": "Remedium Life",
    "stock_name": "Remedium Life",
    "full_name": "Remedium Lifecare Ltd",
    "name_url": "stocks-analysis/remedium-life",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "0.95",
    "chg": -0.04,
    "chgp": "-4.04%",
    "dir": -1,
    "prev_price": "0.99",
    "mcapval": "83.79 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539561,
    "symbol": "",
    "ind_name": "Trading & Distributors",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE549S01036",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "1.37 cr",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/remedium-life-857841-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "How has been the historical performance of Remedium Life?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-remedium-life-3726424",
        "imagepath": "",
        "date": "2025-11-24 23:25:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profitability Overview</strong></p>\n<p>For the year ended 31 March 2025, Remedium Life reported total operating income of ₹405.25 crores, entirely derived from net sales, with no other operating income recorded. Despite this revenue base, the company faced substantial expenditure, notably a purchase of finished goods amounting to ₹534.28 crores, which exceeded its sales figure, indicating a high cost structure. The inventory adjustment showed a negative figure of ₹136.15 crores, reflecting an increase in stock levels during the period.</p>\n<p>Operating expenses beyond purchases were minimal, with employee costs at ₹0.76 crores and other expenses totalling ₹7.44 crores. The total expenditure excluding depreciation stood at ₹406.34 crores, marginally surpassing operating income, re..."
      },
      {
        "title": "Are Remedium Life latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-remedium-life-latest-results-good-or-bad-3726169",
        "imagepath": "",
        "date": "2025-11-24 19:11:03",
        "description": "Remedium Lifecare's latest financial results for Q2 FY26 present a mixed picture, highlighting both notable achievements and significant concerns. The company reported a net profit of ₹8.62 crores, reflecting a substantial quarter-on-quarter increase of 85.38%. However, this improvement is overshadowed by a decline in net sales, which totaled ₹111.06 crores, down 2.04% from the previous quarter. This decline in sales continues a troubling trend, as it follows a much larger drop in the prior quarter and is significantly lower than the sales figures from earlier quarters.\n\nThe operating profit margin, excluding other income, improved to 6.64% from a previous low of 1.65%, suggesting some progress in cost management. Nevertheless, the reliance on non-operating income, which constituted approximately 30.61% of the operating profit, raises questions about the sustainability of this profitability. The company’s b..."
      },
      {
        "title": "Remedium Lifecare Q2 FY26: Profitability Surge Masks Deeper Structural Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/remedium-lifecare-q2-fy26-profitability-surge-masks-deeper-structural-concerns-3726156",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/RemediumLifecar_quaterlyResult_3726156.png",
        "date": "2025-11-24 16:52:04",
        "description": "Remedium Lifecare Ltd., a micro-cap trading and distribution company, reported a striking 85.38% quarter-on-quarter surge in net profit to ₹8.62 crores for Q2 FY26, recovering from the ₹4.65 crores recorded in Q1 FY26. However, the apparent profitability improvement belies fundamental weaknesses that have driven the stock down 69.42% over the past year, with shares currently trading at ₹1.27—a far cry from the 52-week high of ₹4.28."
      },
      {
        "title": "How has been the historical performance of Remedium Life?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-remedium-life-3704026",
        "imagepath": "",
        "date": "2025-11-15 00:22:30",
        "description": "Answer:\nThe historical performance of Remedium Life shows a total operating income of 405.25 Cr for the year ending March 2025, with a total expenditure of 406.34 Cr, resulting in an operating profit (PBDIT) of -1.09 Cr. After accounting for other income of 10.80 Cr, the operating profit stands at 9.71 Cr. The profit before tax is reported at 4.38 Cr, leading to a profit after tax of 2.13 Cr. The earnings per share (EPS) is 0.04, with a profit after tax margin of 0.53%. The company has no long-term borrowings and total liabilities amounting to 1,720.31 Cr, while total assets are equal to the same figure. The cash flow from operating activities is negative at -1,134.00 Cr, but cash flow from financing activities shows a positive inflow of 1,136.00 Cr, resulting in a net cash inflow of 1.00 Cr.\n\nBreakdown:\nRemedium Life's financial results for March 2025 indicate a total operating income of 405.25 Cr, with ex..."
      },
      {
        "title": "Why is Remedium Life falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-remedium-life-fallingrising-3672654",
        "imagepath": "",
        "date": "2025-11-05 00:00:00",
        "description": "As of 04-Nov, Remedium Lifecare Ltd's stock price is currently at 1.59, reflecting an increase of 0.09 or 6.0%. The stock has shown a strong performance today, outperforming its sector by 6.78%. Additionally, it has demonstrated a notable rise in investor participation, with a delivery volume of 88.4 lacs on 03 Nov, which is up by 106.75% compared to the 5-day average. In terms of returns, the stock has increased by 3.25% over the past week, while it has seen a decline of 55.52% year-to-date and 62.91% over the past year, indicating a significant recovery in the short term despite its longer-term struggles. There is no information available regarding positive or negative factors that could further explain the stock's recent movement.\n\nBroader market context shows that while Remedium Lifecare Ltd has outperformed the Sensex by 3.63% over the past week, the benchmark itself has declined by 1.38%. This indicat..."
      },
      {
        "title": "Why is Remedium Life falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-remedium-life-fallingrising-3568283",
        "imagepath": "",
        "date": "2025-09-24 23:19:05",
        "description": "As of 24-Sep, Remedium Lifecare Ltd's stock price is currently at 1.50, showing no change (0.00%). The stock's performance today is inline with the sector, and it is trading higher than its 20-day, 50-day, and 100-day moving averages, but lower than its 5-day and 200-day moving averages. The stock has seen a delivery volume of 1.43 crore on 23 September, which is a 25.35% increase compared to the 5-day average, indicating rising investor participation. However, the company has a high Debt to EBITDA ratio of -1.00 times and has reported losses over the last four consecutive quarters, contributing to a negative return on capital employed (ROCE) and poor long-term growth. The stock has underperformed significantly over the past year, with a return of -76.28%, compared to the benchmark's negative return of -5.32%.\n\nIn the broader market context, while the Sensex has shown a slight gain of 0.50% over the past mo..."
      },
      {
        "title": "Why is Remedium Life falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-remedium-life-fallingrising-3562250",
        "imagepath": "",
        "date": "2025-09-23 23:29:10",
        "description": "As of 23-Sep, Remedium Lifecare Ltd's stock price is currently at 1.50, reflecting a decrease of 0.05 or 3.23%. The stock has underperformed its sector by 1.65% today and has experienced a trend reversal, falling after three consecutive days of gains. In terms of returns, the stock has shown a decline of 0.66% over the past week and a significant drop of 58.03% year-to-date. Additionally, the delivery volume has decreased by 18.12% compared to the five-day average, indicating falling investor participation. The stock's performance is also characterized by moving averages that are higher than the 20-day, 50-day, and 100-day averages but lower than the 5-day and 200-day averages, suggesting mixed momentum.\n\nBroader Market Context: The Sensex, a benchmark index, has declined by 0.34% over the past week, indicating that the broader market is also experiencing some downward pressure. However, Remedium Lifecare's..."
      },
      {
        "title": "Why is Remedium Life falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-remedium-life-fallingrising-3555483",
        "imagepath": "",
        "date": "2025-09-22 23:19:13",
        "description": "As of 22-Sep, Remedium Lifecare Ltd's stock price is currently at 1.55, reflecting an increase of 0.03 or 1.97%. The stock has shown a positive trend recently, having outperformed its sector by 2.21% today and achieving consecutive gains over the last two days, resulting in a total return of 3.33% during this period. However, despite these short-term gains, the company faces significant challenges, including a high Debt to EBITDA ratio of -1.00 times, indicating a low ability to service debt, and a history of negative financial performance with reported losses over the last four consecutive quarters. The company has also experienced a drastic decline in net sales of -76.36%, contributing to its poor long-term growth prospects.\n\nIn the broader market context, the stock has outperformed the Sensex in the short term, with a 1-week return of +1.97% compared to the benchmark's +0.46%. However, the stock has unde..."
      },
      {
        "title": "Why is Remedium Life falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-remedium-life-fallingrising-3540049",
        "imagepath": "",
        "date": "2025-09-19 23:14:21",
        "description": "As of 19-Sep, Remedium Lifecare Ltd's stock price is currently at 1.52, reflecting an increase of 0.02 or 1.33%. The stock has shown a performance of 16.03% over the past month, although it has significantly underperformed over the year with a decline of 76.31%. Today's price summary indicates that the stock has outperformed its sector by 1.79%, and it is trading higher than its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below its 200-day moving average. However, there is a concerning trend with a 27.73% drop in delivery volume compared to the 5-day average, suggesting falling investor participation. Additionally, the company faces significant challenges, including a high Debt to EBITDA ratio of -1.00 times, negative returns on capital employed, and a drastic decline in net sales, which has contributed to its poor long-term growth outlook.\n\nIn the broader market context, the sto..."
      }
    ],
    "total": 500,
    "sid": "857841",
    "stock_news_url": "https://www.marketsmojo.com/news/remedium-lifecare-857841"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "17-Nov-2025",
      "details": "Remedium Lifecare Delivers Strong Q2 Results with Profit Nearly Doubling to Rs.862.34 Lakh",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "17-Nov-2025",
      "details": "Newspaper Publication for unaudited financial results 30.09.2025",
      "source": "BSE"
    },
    {
      "caption": "Results - Financial Results For Quarter And Half Year Ended September 30 2025",
      "datetime": "14-Nov-2025",
      "details": "Financial Results for Quarter and Half Year ended September 30 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Remedium Lifecare Ltd has announced <strong>1:5</strong> stock split, ex-date: 23 Feb 24",
          "dt": "2024-02-23",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Remedium Lifecare Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 05 Jul 24",
          "dt": "2024-07-05",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Remedium Lifecare Ltd has announced <strong>61:50</strong> rights issue, ex-date: 15 Apr 25",
          "dt": "2025-04-15",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

How has been the historical performance of Remedium Life?

2025-11-24 23:25:17

Revenue and Profitability Overview

For the year ended 31 March 2025, Remedium Life reported total operating income of ₹405.25 crores, entirely derived from net sales, with no other operating income recorded. Despite this revenue base, the company faced substantial expenditure, notably a purchase of finished goods amounting to ₹534.28 crores, which exceeded its sales figure, indicating a high cost structure. The inventory adjustment showed a negative figure of ₹136.15 crores, reflecting an increase in stock levels during the period.

Operating expenses beyond purchases were minimal, with employee costs at ₹0.76 crores and other expenses totalling ₹7.44 crores. The total expenditure excluding depreciation stood at ₹406.34 crores, marginally surpassing operating income, re...

Are Remedium Life latest results good or bad?

2025-11-24 19:11:03

Remedium Lifecare's latest financial results for Q2 FY26 present a mixed picture, highlighting both notable achievements and significant concerns. The company reported a net profit of ₹8.62 crores, reflecting a substantial quarter-on-quarter increase of 85.38%. However, this improvement is overshadowed by a decline in net sales, which totaled ₹111.06 crores, down 2.04% from the previous quarter. This decline in sales continues a troubling trend, as it follows a much larger drop in the prior quarter and is significantly lower than the sales figures from earlier quarters. The operating profit margin, excluding other income, improved to 6.64% from a previous low of 1.65%, suggesting some progress in cost management. Nevertheless, the reliance on non-operating income, which constituted approximately 30.61% of the operating profit, raises questions about the sustainability of this profitability. The company’s b...

Remedium Lifecare Q2 FY26: Profitability Surge Masks Deeper Structural Concerns

2025-11-24 16:52:04

Remedium Lifecare Ltd., a micro-cap trading and distribution company, reported a striking 85.38% quarter-on-quarter surge in net profit to ₹8.62 crores for Q2 FY26, recovering from the ₹4.65 crores recorded in Q1 FY26. However, the apparent profitability improvement belies fundamental weaknesses that have driven the stock down 69.42% over the past year, with shares currently trading at ₹1.27—a far cry from the 52-week high of ₹4.28.

How has been the historical performance of Remedium Life?

2025-11-15 00:22:30

Answer: The historical performance of Remedium Life shows a total operating income of 405.25 Cr for the year ending March 2025, with a total expenditure of 406.34 Cr, resulting in an operating profit (PBDIT) of -1.09 Cr. After accounting for other income of 10.80 Cr, the operating profit stands at 9.71 Cr. The profit before tax is reported at 4.38 Cr, leading to a profit after tax of 2.13 Cr. The earnings per share (EPS) is 0.04, with a profit after tax margin of 0.53%. The company has no long-term borrowings and total liabilities amounting to 1,720.31 Cr, while total assets are equal to the same figure. The cash flow from operating activities is negative at -1,134.00 Cr, but cash flow from financing activities shows a positive inflow of 1,136.00 Cr, resulting in a net cash inflow of 1.00 Cr. Breakdown: Remedium Life's financial results for March 2025 indicate a total operating income of 405.25 Cr, with ex...

Why is Remedium Life falling/rising?

2025-11-05 00:00:00

As of 04-Nov, Remedium Lifecare Ltd's stock price is currently at 1.59, reflecting an increase of 0.09 or 6.0%. The stock has shown a strong performance today, outperforming its sector by 6.78%. Additionally, it has demonstrated a notable rise in investor participation, with a delivery volume of 88.4 lacs on 03 Nov, which is up by 106.75% compared to the 5-day average. In terms of returns, the stock has increased by 3.25% over the past week, while it has seen a decline of 55.52% year-to-date and 62.91% over the past year, indicating a significant recovery in the short term despite its longer-term struggles. There is no information available regarding positive or negative factors that could further explain the stock's recent movement. Broader market context shows that while Remedium Lifecare Ltd has outperformed the Sensex by 3.63% over the past week, the benchmark itself has declined by 1.38%. This indicat...

Why is Remedium Life falling/rising?

2025-09-24 23:19:05

As of 24-Sep, Remedium Lifecare Ltd's stock price is currently at 1.50, showing no change (0.00%). The stock's performance today is inline with the sector, and it is trading higher than its 20-day, 50-day, and 100-day moving averages, but lower than its 5-day and 200-day moving averages. The stock has seen a delivery volume of 1.43 crore on 23 September, which is a 25.35% increase compared to the 5-day average, indicating rising investor participation. However, the company has a high Debt to EBITDA ratio of -1.00 times and has reported losses over the last four consecutive quarters, contributing to a negative return on capital employed (ROCE) and poor long-term growth. The stock has underperformed significantly over the past year, with a return of -76.28%, compared to the benchmark's negative return of -5.32%. In the broader market context, while the Sensex has shown a slight gain of 0.50% over the past mo...

Why is Remedium Life falling/rising?

2025-09-23 23:29:10

As of 23-Sep, Remedium Lifecare Ltd's stock price is currently at 1.50, reflecting a decrease of 0.05 or 3.23%. The stock has underperformed its sector by 1.65% today and has experienced a trend reversal, falling after three consecutive days of gains. In terms of returns, the stock has shown a decline of 0.66% over the past week and a significant drop of 58.03% year-to-date. Additionally, the delivery volume has decreased by 18.12% compared to the five-day average, indicating falling investor participation. The stock's performance is also characterized by moving averages that are higher than the 20-day, 50-day, and 100-day averages but lower than the 5-day and 200-day averages, suggesting mixed momentum. Broader Market Context: The Sensex, a benchmark index, has declined by 0.34% over the past week, indicating that the broader market is also experiencing some downward pressure. However, Remedium Lifecare's...

Why is Remedium Life falling/rising?

2025-09-22 23:19:13

As of 22-Sep, Remedium Lifecare Ltd's stock price is currently at 1.55, reflecting an increase of 0.03 or 1.97%. The stock has shown a positive trend recently, having outperformed its sector by 2.21% today and achieving consecutive gains over the last two days, resulting in a total return of 3.33% during this period. However, despite these short-term gains, the company faces significant challenges, including a high Debt to EBITDA ratio of -1.00 times, indicating a low ability to service debt, and a history of negative financial performance with reported losses over the last four consecutive quarters. The company has also experienced a drastic decline in net sales of -76.36%, contributing to its poor long-term growth prospects. In the broader market context, the stock has outperformed the Sensex in the short term, with a 1-week return of +1.97% compared to the benchmark's +0.46%. However, the stock has unde...

Why is Remedium Life falling/rising?

2025-09-19 23:14:21

As of 19-Sep, Remedium Lifecare Ltd's stock price is currently at 1.52, reflecting an increase of 0.02 or 1.33%. The stock has shown a performance of 16.03% over the past month, although it has significantly underperformed over the year with a decline of 76.31%. Today's price summary indicates that the stock has outperformed its sector by 1.79%, and it is trading higher than its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below its 200-day moving average. However, there is a concerning trend with a 27.73% drop in delivery volume compared to the 5-day average, suggesting falling investor participation. Additionally, the company faces significant challenges, including a high Debt to EBITDA ratio of -1.00 times, negative returns on capital employed, and a drastic decline in net sales, which has contributed to its poor long-term growth outlook. In the broader market context, the sto...

View All News